Bird flu vaccine: What to know
Published On Jan 10, 2025, 2:48 PM
The article discusses the ongoing concerns regarding the H5N1 strain of bird flu, particularly after a fatal case was reported in Louisiana. Medical experts are emphasizing the importance of a bird flu vaccine, which is currently under development by the U.S. government, to protect at-risk populations. The CDC notes that human infections are rare, but the virus has shown the potential to mutate and spread, posing significant threats, especially to those working closely with poultry and other affected animals. Moderna has received funding to develop a vaccine, and experts argue that timely vaccination could be critical in preventing future outbreaks.
Stock Forecasts
MRNA
Positive
With the heightened attention towards the bird flu vaccine development and the recent case reporting, biotechnology and pharmaceutical stocks, particularly those involved in vaccine development like Moderna, could see significant interest. Moderna's recent funding from the U.S. government emphasizes its role in combating pandemics, which may attract investor sentiment favoring positive growth expectations in the stock.
Related News
Stock market today: Dow, S&P 500 inch lower with Trump tariff power move, rate cuts in focus
Jan 8, 2025, 10:10 AM
Investors absorbed a report that President-elect Donald Trump is considering declaring a national economic emergency to pave the way for proposed tariffs.
Five Ways R.F.K. Jr. Could Undermine Lifesaving Childhood Vaccines
Nov 19, 2024, 5:04 AM
If he is confirmed as H.H.S. secretary, the longtime vaccine critic would be in a position to change the government’s immunization recommendations and delay the development of new vaccines.
Stock market today: Dow, S&P 500, Nasdaq sink as post-election rally fades, Fed prompts rate-cut rethink
Nov 15, 2024, 1:15 PM
Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear off.